Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Very warm weather can make it difficult to keep medicines at the temperature they need to be. Get tips for proper storage.
A new CSL Vifor manufacturing facility in St. Gallen, Switzerland, has a modular design that can be expanded – cube by cube –…
CSL is partnering with the Association of Australian Medical Research Institutes (AAMRI) to sponsor the AAMRI Rising Star Awa…
The goal is to keep what you need at hand and know how to access it, but medical record organization can be challenging in a …
Organizations across the globe – including Screen4Rare – are working to bring life-saving screening tests to babies, wherever…
Hemophilia A and B can have similar symptoms, but their underlying causes and potential treatments differ.
CSL’s Dr. Greg Kato was part of a team who published a review article about iron restriction in the American Journal of Hemat…
The JNC, celebrating its 22nd year, hosts children and teens in the bleeding disorders community for a weekend full of sports…
Tim Grams, father of four, dove into swimming as a young person and today stays active despite Hemophilia A.
Americas
Asia Pacific
Middle East
Europe
